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Introduction
Poor quality of care remains key constraint to safe
motherhood especially for women from poor families in
a context of rapid expansion of maternity healthcare
services. In India, deliveries at healthcare institutions
have increased in last three years.
There is evidence that oxytocin is a drug is often mis-
used to speed labours (childbirth) in overcrowded labour
w a r d so re v e ni nh o m es e t t i n g s .I nI n d i at h i sp h e n o m -
enon has not been extensively studied, especially since
the expansion of institutional deliveries. To order to
study use of oxytocin, we collected information on
drugs administered for labour augmentation as part of a
prospective study of pregnancy and childbirth in south
India.
Methods
We randomly selected 39 villages across 13 primary
health centres in a rural block of Ramnagar district in
Karnataka. Subsequently we purposively selected 41 vil-
lages located adjacent to villages selected earlier to meet
enrolment target. All women who planned to deliver
w i t h i ns t u d ya r e aa n dw e r ei nt h et h i r dt r i m e s t e ro f
pregnancy were enrolled (642) during 2007-2009.
Of the total number of respondents, 501 women deliv-
ered at healthcare institutions and 99 at home. We con-
ducted in-depth interviews with healthcare providers.
Results
Healthcare providers revealed that oxytocin was the
most commonly available and used drug for labour aug-
mentation. Of the women who delivered child at home,
76.4% were administered oxytocin mainly by an Auxili-
a r yN u r s eM i d w i f e( A N M )i nt h ed o s a g er a n g i n g
between one to five injections. Most of these women
reported that these intramuscularly administered injec-
tions were “to increase labour”. Of the women who gave
delivered child at healthcare institutions, 23% were
administered oxytocin – mainly via intramuscular
injection.
Many women reported that healthcare providers did
not remain present after administration of oxytocin.
Also, the cost of procuring the oxytocin injections were
reported high in spite of subsidised rates.
Discussion
We believe that our study findings would be a conserva-
tive estimate of the extent of oxytocin use since many
women might have received the drug without explana-
tion suggesting unnecessary use in government as well
as private healthcare services.
We recommend need to ensure compliance with clini-
cal protocols and guidelines for the safe use of oxytocin,
a drug critical to safe motherhood but with considerable
scope for misuse.
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